Pharma Technology
Pharma Technology, also known as PharmaTec, is a leading player in the pharmaceutical technology sector, headquartered in the United States. Established in 2001, the company has made significant strides in providing innovative solutions for drug development and manufacturing, with a strong presence in North America and Europe. Specialising in advanced drug delivery systems and formulation development, Pharma Technology stands out for its commitment to quality and efficiency. The company’s core offerings include customised drug formulations and cutting-edge analytical services, which are designed to meet the evolving needs of the pharmaceutical industry. With a reputation for excellence, Pharma Technology has achieved notable milestones, including partnerships with major pharmaceutical firms and recognition for its contributions to enhancing drug efficacy. As a trusted name in the industry, Pharma Technology continues to drive advancements in pharmaceutical innovation.
DitchCarbon Score
How does Pharma Technology's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Pharma Technology's score of 3 is lower than 74% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharma Technology's reported carbon emissions
Pharma Technology, headquartered in the US, currently does not have available carbon emissions data for recent years, as no specific figures have been provided. Consequently, there are no documented Scope 1, 2, or 3 emissions to report. Additionally, the company has not outlined any formal reduction targets or commitments to the Science Based Targets initiative (SBTi) or other climate pledges. In the absence of specific emissions data or reduction initiatives, it is essential to note that the pharmaceutical industry is increasingly focusing on sustainability and reducing carbon footprints. Companies are encouraged to adopt comprehensive climate strategies to align with global efforts to mitigate climate change. As Pharma Technology moves forward, establishing clear emissions data and reduction commitments will be crucial for enhancing its environmental responsibility and transparency.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Pharma Technology is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
